title: Therapeutic effects of nitric oxide-aspirin hybrid drugs.
abstract: This review examines the therapeutic potential and mechanisms of action of drugs known as nitric oxide (NO)-aspirins. Drugs of this class have an NO-releasing moiety joined by ester linkage to the aspirin molecule. NO-aspirins have the capability to release NO in addition to retaining the cyclooxygenase-inhibitory action of aspirin. The protective nature of NO led to the development of NO-aspirins in the hope that they might avoid the gastric side effects associated with aspirin. However, it has become apparent that the drug-derived NO instills potential for a wide range of added beneficial effects over the parent compound. In this review, the authors focus on the analgesic, anti-inflammatory, cardiovascular and chemopreventative actions of compounds of this emerging drug class.
authors.affiliation: Queen's Medical Research Institute, University of Edinburgh, Centre for Cardiovascular Science, Edinburgh, EH16 4TJ, UK. s9901288@sms.ed.ac.uk
authors.forename: Catriona M
authors.initials: CM
authors.lastname: Turnbull
authors.forename: Adriano G
authors.initials: AG
authors.lastname: Rossi
authors.forename: Ian L
authors.initials: IL
authors.lastname: Megson
mesh_terms: D000700:Analgesics / Q000737:chemistry / Q000627:therapeutic use*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D001241:Aspirin / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009569:Nitric Oxide / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D009569:Nitric Oxide; D001241:Aspirin